McDermott + Bull has successfully placed Julianna Uresch as Senior Director of Upstream Marketing at Vista.ai. In this role, Julianna will lead product strategy and market development for Vista.ai’s AI-powered MRI platform, Vista Cardiac, and future applications...
McDermott + Bull Partner Ken Dropiewski sits down with Founding Partner, Tasneem Dohadwala from Excelestar Ventures to explore essential topics for investors in the MedTech space. In this wide-ranging interview, Tasneem shares Excelestar’s investment focus, what they...
McDermott + Bull Partner Ken Dropiewski sits down with KCK Group’s Senior Managing Director Greg Garfield to explore essential topics for investors in the MedTech space. Greg provides an inside look at KCK Group’s typical investment and team structure, as...
McDermott + Bull has successfully placed Michael Selberis as Chief Technology Officer at ClinNEXUS. Michael will lead the development and execution of ClinNEXUS’s technology strategy, overseeing all aspects of technological direction to ensure alignment with the...
McDermott + Bull has successfully placed Courtney Walton as Vice President of Quality & Regulatory at Natus Neuro. Courtney will be reporting directly to the Chief Executive Officer and will lead the company’s efforts to achieve and maintain excellence in quality...
What a difference a year makes. In the first half of 2024, the MedTech sector showed a notable uptick in M&A activity, with 114 acquisitions valued at $40.3 billion — close to last year’s total. Despite fewer venture rounds, funding remained strong at $9.7...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
